LONDON, Dec 29 (Reuters) - Ask executives in the healthcare industry about the future market for weight-loss drugs and the analogies are telling: monthly GLP-1 medicine subscriptions like a streaming video membership; dose decisions managed on a smartphone app; access made as easy as buying a pair of Nikes. This is their vision of the consumerization of weight-loss as drugmakers Novo Nordisk and Eli Lilly prepare to launch pill versions alongside their blockbuster injectable treatments and incr

The historical backdrop of civic establishments is a rich embroidery loaded up with enthralling stories and wonderful accomplishments. Investigating these antiquated societies not

Here's how to lock in Paramount+'s current pricing before they raise their rates.